Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy

被引:21
作者
Chometon, Gretel [1 ]
Jendrossek, Verena [1 ]
机构
[1] Univ Duisburg Essen, Dept Mol Cell Biol, Inst Cell Biol, D-45122 Essen, Germany
关键词
Microenvironment; Treatment resistance; Radiotherapy; Reactive stroma; TRAIL RECEPTOR ANTIBODIES; LUNG-CANCER CELLS; PROSTATE-CANCER; DRUG-RESISTANCE; DNA-DAMAGE; PHASE-I; PANCREATIC-CANCER; ENDOTHELIAL-CELLS; BASEMENT-MEMBRANE; INDUCED APOPTOSIS;
D O I
10.1007/s12094-009-0317-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The impact of a favourable microenvironment on tumour progression is a limiting factor for current tumour therapy protocols, as it contributes to the selection of resistant tumour cells. Apart from immune and inflammatory cells, the extracellular matrix, cancer-associated fibroblasts and vascular endothelial cells are crucial mediators of protective signals. An important research effort exposes potential environmental targets that may define new therapeutic strategies for solid tumours.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 101 条
[1]
Structure and biological activity of the extracellular matrix [J].
Aumailley, M ;
Gayraud, B .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4) :253-265
[2]
Immunology for the next generation [J].
Balkwill, F .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (06) :509-512
[3]
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors [J].
Baluk, P ;
Morikawa, S ;
Haskell, A ;
Mancuso, M ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1801-1815
[4]
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[5]
Apoptosis-modulating agents in combination with radiotherapy-current status and outlook [J].
Belka, C ;
Jendrossek, V ;
Pruschy, M ;
Vink, S ;
Verheij, M ;
Budach, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (02) :542-554
[6]
A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo [J].
Bhaskar, Vinay ;
Zhang, Dong ;
Fox, Melvin ;
Seto, Pui ;
Wong, Melanie H. L. ;
Wales, Pauline E. ;
Powers, David ;
Chao, Debra T. ;
DuBridge, Robert B. ;
Ramakrishnan, Vanitha .
JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5
[7]
Stromal fibroblasts in cancer initiation and progression [J].
Bhowmick, NA ;
Neilson, EG ;
Moses, HL .
NATURE, 2004, 432 (7015) :332-337
[8]
TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia [J].
Bhowmick, NA ;
Chytil, A ;
Plieth, D ;
Gorska, AE ;
Dumont, N ;
Shappell, S ;
Washington, MK ;
Neilson, EG ;
Moses, HL .
SCIENCE, 2004, 303 (5659) :848-851
[9]
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells [J].
Bianco, Roberto ;
Rosa, Roberta ;
Damiano, Vincenzo ;
Daniele, Gennaro ;
Gelardi, Teresa ;
Garofalo, Sonia ;
Tarallo, Valeria ;
De Falco, Sandro ;
Melisi, Davide ;
Benelli, Roberto ;
Albini, Adriana ;
Ryan, Anderson ;
Ciardiello, Fortunato ;
Tortora, Giampaolo .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5069-5080
[10]
Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model [J].
Bisanz, K ;
Yu, J ;
Edlund, M ;
Spohn, B ;
Hung, MC ;
Chung, LWK ;
Hsieh, CL .
MOLECULAR THERAPY, 2005, 12 (04) :634-643